nach oben

AIDS and Behavior

Erschienen in:

21.05.2019 | Original Paper

Understanding the Prevalence of Smoking Among People Living with HIV (PLHIV) in Australia and Factors Associated with Smoking and Quitting

verfasst von: Stephanie K. Edwards, Judith Dean, Jennifer Power, Peter Baker, Coral Gartner

Erschienen in: AIDS and Behavior | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Understanding contributors to smoking and quitting cigarettes is important to developing effective cessation programs and addressing smoking related morbidity and mortality among people living with HIV (PLHIV). Using data from a large cross-sectional study of Australian PLHIV we provide a smoking prevalence estimate and explore the relationship between socio-demographic variables and smoking status. We also explore the relationship between HIV diagnosis and antiretroviral therapy (ART) initiation and quitting smoking. Of the 1011 respondents included in the analysis, 30.6% were current smokers. The strongest predictor of smoking was regular cannabis use (AOR 6.2, 95% CI 3.6–10.8) while the strongest predictor of being a past smoker was receiving ART (AOR 2.4, 95% CI 1.2–4.7). Quitting also increased around the time of diagnosis and ART initiation, highlighting the potential for these events to be optimal times to address smoking among PLHIV.

Nur mit Berechtigung zugänglich

Benard A, Bonnet F, Tessier J-F, et al. Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 aquitaine cohort. AIDS Patient Care ST. 2007;21(7):458–68.CrossRef

Gritz ER, Danysh HE, Fletcher FE, et al. Long-term outcomes of a cell phone-delivered intervention for smokers living with HIV. Clin Infect Dis. 2013;57(4):608–15.CrossRefPubMedPubMedCentral

Burkhalter JE, Springer CM, Chhabra R, Ostroff JS, Rapkin BD. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res. 2005;7(4):511–22.CrossRefPubMed

Feldman JG, Minkoff H, Schneider MF, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women’s interagency HIV study. Am J Public Health. 2006;96(6):1060–5.CrossRefPubMedPubMedCentral

Tesoriero JM, Gieryic SM, Carrascal A, Lavigne HE. Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS Behav. 2010;14:824–35.CrossRefPubMed

Webb MS, Vanable PA, Carey MP, Blair DC. Cigarette smoking among HIV + men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum. J Behav Med. 2007;30:371–83.CrossRefPubMedPubMedCentral

Lifson AR, Neuhaus J, Arribas JR, van den Berg-Wolf M, Labriola AM, Read TRH. Smoking-related health risks among persons with HIV in the strategies for management of antiretroviral therapy clinical trial. Am J Public Health. 2010;100(10):1896–903.CrossRefPubMedPubMedCentral

Marshall MM, Kirk GD, Caporaso NE, et al. Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users. Addict Behav. 2011;36:61–7.CrossRefPubMed

Elf JL, Variava E, Chon S, et al. Prevalence and correlates of smoking among people living with HIV in South Africa. Nicotine Tob Res. 2018;20(9):1124–31.CrossRefPubMed

10.

Mdodo R, Frazier EL, Dube SR, et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann Intern Med. 2015;162(5):335–44.CrossRefPubMed

11.

Regan S, Meigs JB, Grinspoon SK, Triant VA. Determinants of smoking and quitting in HIV-infected individuals. PLoS ONE. 2016;11(4):e153103.CrossRef

12.

Shirley DK, Kaner RJ, Glesby MJ. Effects of smoking on non-AIDS-related morbidity in HIV-infected patients. Clin Infect Dis. 2013;57(2):275–82.CrossRefPubMedPubMedCentral

13.

Helleberg M, May MT, Ingle SM, et al. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. AIDS. 2015;29(2):221–9.CrossRefPubMed

14.

Savin MJ, Frank-Pearce SG, Pulvers K, Vidrine DJ. The association between lifetime polytobacco use and intention to quit among HIV-positive cigarette smokers. Drug Alcohol Depend. 2018;191:152–8.CrossRefPubMedPubMedCentral

15.

Ellard J. Smoking cessation interventions: a literature review [Internet]. National Federation of AIDs Organisations Inc, 2010.

16.

Akhtar-Khaleel WZ, Cook RL, Shoptaw S, et al. Trends and predictors of cigarette smoking among HIV seropositive and seronegative men: the multicenter aids cohort study. AIDS Behav. 2016;20(3):622–32.CrossRefPubMedPubMedCentral

17.

Mdege ND, Shah S, Ayo-Yusuf OA, Hakim J, Siddiqi K. Tobacco use among people living with HIV: analysis of data from demographic and health surveys from 28 low-income and middle-income countries. Lancet Glob Health. 2017;5(6):e578–92.CrossRefPubMedPubMedCentral

18.

Garrett BE, Dube SR, Babb S, McAfee T. Addressing the social determinants of hto reduce tobacco-related disparities. Nicotine Tob Res. 2015;17(8):892–7.CrossRefPubMed

19.

Humfleet GL, Delucchi K, Kelley K, Hall SM, Dilley J, Harrison G. Characteristics of HIV-positive cigarette smokers: a sample of smokers facing multiple challenges. AIDS Educ Prev. 2009;21(3 Suppl):54–64.CrossRefPubMedPubMedCentral

20.

Murphy JD, Liu B, Parascandola M. Smoking and HIV in sub-Saharan Africa: a 25 country analysis of the demographic health surveys. Nicotine Tob Res. 2018. https://doi.org/10.1093/ntr/nty176.CrossRefPubMedPubMedCentral

21.

Vidrine DJ. Cigarette smoking and HIV/AIDS: health implications, smoker characteristics and cessation strategies. AIDS Educ Prev. 2009;21:3.CrossRefPubMedPubMedCentral

22.

Pacek LR, Crum RM. A review of the literature concerning HIV and cigarette smoking: morbidity and mortality, associations with individual- and social-level characteristics, and smoking cessation efforts. Addict Res Theory. 2015;23(1):10–23.CrossRefPubMed

23.

Colon-Lopez V, Gonzalez-Barrios D, De Leon SM, et al. Population-based study of tobacco use among people living with HIV in Puerto Rico. Subst Use Misuse. 2018;53(3):420–5.CrossRefPubMed

24.

Bénard A, Tessier JF, Rambeloarisoa J, et al. HIV infection and tobacco smoking behaviour: prospects for prevention? ANRS CO3 Aquitaine Cohort, 2002. Int J Tuberc Lung Dis. 2006;10(4):378–83.PubMed

25.

Gritz ER, Vidrine DJ, Lazev AB, Amick BC III, Arduino RC. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res. 2004;6(1):71–7.CrossRefPubMed

26.

Cummins D, Trotter G, Moussa M, Turham G. Smoking cessation for clients who are HIV-positive. Nurs Stand. 2005;12:41–7.CrossRef

27.

Uthman OA, Ekstrom AM, Moradi TT. Influence of socioeconomic position and gender on current cigarette smoking among people living with HIV in sub-Saharan Africa: disentangling context from composition. BMC Public Health. 2016;16:998.CrossRefPubMedPubMedCentral

28.

King D, Grasso C, Dant L, et al. Treatment outcomes associated with quitting cigarettes among sexual minority men living with HIV: antiretroviral adherence, engagement in care, and sustained HIV RNA suppression. AIDS Behav. 2018;22(9):2868–76.CrossRefPubMed

29.

McBride CM, Lipkus IM, Emmons KM. Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res. 2003;18(2):156–70.CrossRefPubMed

30.

Collins RL, Kanouse DE, Gifford AL, et al. Changes in health-promoting behavior following diagnosis with HIV: prevalence and correlates in a national probability sample. Health Psychol. 2001;20(5):351–60.CrossRefPubMed

31.

Vidrine DJ, Frank SG, Savin MJ, et al. HIV care initiation: a teachable moment for smoking cessation? Nicotine Tob Res. 2017;20(9):1109–16.CrossRefPubMedCentral

32.

Grierson J, Pitts M, Koelmeyer R. HIV futures seven: the health and wellbeing of HIV positive people in Australia. Melbourne: Latrobe University; 2013.

33.

IBM Corp. IBM SPSS Statistics for Windows, Version 23.0. Armonk, NY: IBM Corp; Released 2015.

34.

Australian Bureau of Statistics. Australian health survey: first results, 2011–12 Canberra: Commonwealth of Australia, 2012.

35.

Fuster M, Estrada V, Fernandez-Pinilla MC, et al. Smoking cessation in HIV patients: rate of success and associated factors. HIV Med. 2009;10:614–9.CrossRefPubMed

36.

Matthews AK, Conrad M, Kuhns L, Vargas M, King AC. Project exhale: preliminary evaluation of a tailored smoking cessation treatment for HIV-positive African American smokers. AIDS Patient Care STDS. 2013;27(1):22–32.CrossRefPubMed

37.

Gonzalez A, Barinas J, O’Cleirigh C. Substance use: impact on adherence and HIV medical treatment. Curr HIV/AIDS Rep. 2011;8(4):223–34.CrossRefPubMed

38.

Shepherd L, Ryom L, Law M, et al. Cessation of cigarette smoking and the impact on cancer incidence in human immunodeficiency virus-infected persons: the data collection on adverse events of anti-HIV drugs study. Clin Infect Dis. 2019;68(4):650–7.CrossRefPubMed

39.

Australian Institute of Health and Welfare (AIHW). Alcohol, tobacco and other drugs in Australia. Commonwealth of Australia, 2018.

40.

Cui Q, Robinson L, Elston D, et al. Safety and tolerability of varenicline tartrate (Champix((R))/Chantix((R))) for smoking cessation in HIV-infected subjects: a pilot open-label study. AIDS Patient Care STDS. 2012;26(1):12–9.CrossRefPubMedPubMedCentral

41.

Ingersoll KS, Cropsey KL, Heckman CJ. A test of motivational plus nicotine replacement interventions for HIV positive smokers. AIDS Behav. 2009;13(3):545–54.CrossRefPubMed

42.

Lloyd-Richardson EE, Stanton CA, Papandonatos GD, et al. Motivation and patch treatment for HIV + smokers: a randomized controlled trial. Addiction. 2009;104(11):1891–900.CrossRefPubMedPubMedCentral

43.

Vidrine DJ, Arduino RC, Lazev AB, Gritz ER. A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS. 2006;20(2):253–60.CrossRefPubMed

44.

Vidrine DJ, Marks RM, Arduino RC, Gritz ER. Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes. Nicotine Tob Res. 2012;14(1):106–10.CrossRefPubMed

45.

Scollo MM, Winstanley MH. Tobacco in Australia: facts and issues. Melbourne: Cancer Counc Vic; 2015.

46.

Brath H, Grabovac I, Schalk H, Degen O, Dorner TE. Prevalence and correlates of smoking and readiness to quit smoking in people living with HIV in Austria and Germany. PLoS ONE. 2016;11(2):e0150553.CrossRefPubMedPubMedCentral

47.

Bekele T, Rueda S, Gardner S, et al. Trends and correlates of cigarette smoking and its impacts on health-related quality of life among people living with HIV: findings from the Ontario HIV treatment network cohort study, 2008-2014. AIDS Patient Care STDS. 2017;31(2):49–59.CrossRefPubMed

48.

Twyman L, Bonevski B, Paul C, Bryant J. Perceived barriers to smoking cessation in selected vulnerable groups: a systematic review of the qualitative and quantitative literature. BMJ Open. 2014;4(12):e006414.CrossRefPubMedPubMedCentral

49.

Pacek LR, Harrell PT, Martins SS. Cigarette smoking and drug use among a nationally representative sample of HIV-positive individuals. Am J Addict. 2014;23(6):582–90.CrossRefPubMedPubMedCentral

50.

Grabovac I, Meilinger M, Schalk H, Leichsenring B, Dorner TE. Prevalence and associations of illicit drug and polydrug use in people living with HIV in Vienna. Sci Rep. 2018;8(1):8046.CrossRefPubMedPubMedCentral

51.

Garin N, Zurita B, Velasco C, et al. Prevalence and clinical impact of recreational drug consumption in people living with HIV on treatment: a cross-sectional study. BMJ Open. 2017;7(1):e014105.CrossRefPubMedPubMedCentral

52.

Duval X, Baron G, Garelik D, et al. Living with HIV, antiretroviral treatment experience and tobacco smoking: results from a multisite cross-sectional study. Antivir Ther. 2008;13(3):389–97.PubMedPubMedCentral

53.

Vijayaraghavan M, Penko J, Vittinghoff E, Bangsberg DR, Miaskowski C, Kushel MB. Smoking behaviors in a community-based cohort of HIV-infected indigent adults. AIDS Behav. 2014;18(3):535–43.CrossRefPubMedPubMedCentral

54.

Chew D, Steinberg MB, Thomas P, Swaminathan S, Hodder SL. Evaluation of a smoking cessation program for HIV infected individuals in an urban HIV clinic: challenges and lessons learned. AIDS Res Treat. 2014;2014:237834.PubMedPubMedCentral

55.

Mitton JA, North CM, Muyanja D, et al. Smoking cessation after engagement in HIV care in rural Uganda. AIDS Care. 2018;30(12):1622–9.CrossRefPubMedPubMedCentral

56.

Shuter J, Bernstein SL. Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine Tob Res. 2008;10(4):731–6.CrossRefPubMed

57.

Brown G, Mikołajczak G, Lyons A, et al. Development and validation of PozQoL: a scale to assess quality of life of PLHIV. BMC Public Health. 2018;18(1):527.CrossRefPubMedPubMedCentral

58.

Pool ERM, Dogar O, Lindsay RP, Weatherburn P, Siddiqi K. Interventions for tobacco use cessation in people living with HIV and AIDS. Cochrane Database Syst Rev. 2016(6).

59.

Rabin RA, George TP. A review of co-morbid tobacco and cannabis use disorders: possible mechanisms to explain high rates of co-use. Am J Addict. 2015;24(2):105–16.CrossRefPubMed

Titel: Understanding the Prevalence of Smoking Among People Living with HIV (PLHIV) in Australia and Factors Associated with Smoking and Quitting
verfasst von: Stephanie K. Edwards
Judith Dean
Jennifer Power
Peter Baker
Coral Gartner
Publikationsdatum: 21.05.2019
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 4/2020
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-019-02535-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2020

The Impact of Clinic Policy Attendance and the Ryan White HIV/AIDS Medical Case Management Program on HIV Clinical Outcomes: A Retrospective Longitudinal Study

A Path Analysis of Patient and Social-Level Factors on Health Literacy and Retention in Care Among African Americans Living with HIV

Promoting Tuberculosis Preventive Therapy for People Living with HIV in South Africa: Interventions Hindered by Complicated Clinical Guidelines and Imbalanced Patient-Provider Dynamics

Behavioral Weight Loss: A Promising Treatment for Obesity in Adults with HIV

Patients’ Satisfaction with HIV Care Providers in Public Health Facilities in Lusaka: A Study of Patients who were Lost-to-Follow-Up from HIV Care and Treatment